Zhejiang Yatai Pharmaceutical Co.,Ltd.
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 2001-12-31
- Employees
- 528
- Market Cap
- -
- Website
- www.ytyaoye.com
- Introduction
The company, formerly known as Zhejiang Asia Pacific Pharmaceutical Factory, was founded in 1989 and is now located at No. 36 Nanbin West Road, Lihai Street, Yuecheng District, Shaoxing City, Zhejiang Province. The shareholding system reform was completed in December 2001, and officially listed on the Shenzhen Stock Exchange on March 16, 2010. Currently, the company's products cover several major sectors such as chemical preparations, chemical raw materials, and drug research and development. Ningbo Fubon Holding Group is a large private group integrating commerce, real estate, energy, sports and other industries, and has been listed as a top 500 enterprise over the years. On April 15, 2022, Fubon Group joined Asia Pacific Pharmaceutical as the controlling shareholder, and Asia Pacific Pharmaceutical became a member of the big health industry chain under Fubon Group. The company's main business is pharmaceutical manufacturing, including R&D, production and sales of chemical agents. The main customers are pharmaceutical businesses, distribution companies and medical institutions. The company's main products are antibiotics, antiviral, cardiovascular, digestive, antipyretic and analgesic chemicals. Corporate honors: Enterprise Credit Rating AAA; Shaoxing County Advanced Tax Payment Unit; Shaoxing County Advanced Tax Payment Unit; Shaoxing County Family Planning Advanced Unit; Shaoxing County Enterprise Credit Rating AAA, etc.
Clinical Trials
0
Trial Phases
0 Phases
Drug Approvals
116
Drug Approvals
Tigecycline for Injection
- Product Name
- 注射用替加环素
- Approval Number
- 国药准字H20253298
- Approval Date
- Jan 24, 2025
Cefmetazole Sodium for Injection
- Product Name
- 注射用头孢美唑钠
- Approval Number
- 国药准字H20247311
- Approval Date
- Dec 11, 2024
Cefmetazole Sodium for Injection
- Product Name
- 注射用头孢美唑钠
- Approval Number
- 国药准字H20247312
- Approval Date
- Dec 11, 2024
Esomeprazole Sodium for Injection
- Product Name
- 注射用艾司奥美拉唑钠
- Approval Number
- 国药准字H20203030
- Approval Date
- Sep 13, 2024
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20247191
- Approval Date
- Aug 15, 2024
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20247192
- Approval Date
- Aug 15, 2024
Cefamandole Nafate for Injection
- Product Name
- 注射用头孢孟多酯钠
- Approval Number
- 国药准字H20143231
- Approval Date
- Mar 1, 2024
Terazosin Hydrochloride Tablets
- Product Name
- 盐酸特拉唑嗪片
- Approval Number
- 国药准字H20084527
- Approval Date
- Sep 4, 2023
Cefoxitin Sodium for Injection
- Product Name
- 注射用头孢西丁钠
- Approval Number
- 国药准字H20084336
- Approval Date
- Jun 8, 2023
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next